BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22064373)

  • 21. Prothrombotic State in Atrial Fibrillation Patients With One Additional Risk Factor of the CHA
    Głowicki B; Matusik PT; Plens K; Undas A
    Can J Cardiol; 2019 May; 35(5):634-643. PubMed ID: 30955928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assays of fibrin network properties altered by VKAs in atrial fibrillation - importance of using an appropriate coagulation trigger.
    Ząbczyk M; Blombäck M; Majewski J; Karkowski G; Wallen HN; Undas A; He S
    Thromb Haemost; 2015 Apr; 113(4):851-61. PubMed ID: 25518887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator.
    Ribo M; Montaner J; Molina CA; Arenillas JF; Santamarina E; Quintana M; Alvarez-Sabín J
    Stroke; 2004 Sep; 35(9):2123-7. PubMed ID: 15243150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a TAFI-inhibitor combined with a suboptimal dose of rtPA in a murine thromboembolic model of stroke.
    Durand A; Chauveau F; Cho TH; Kallus C; Wagner M; Boutitie F; Maucort-Boulch D; Berthezène Y; Wiart M; Nighoghossian N
    Cerebrovasc Dis; 2014; 38(4):268-75. PubMed ID: 25401979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombin activatable fibrinolysis inhibitor antigen levels are inversely correlated with plasminogen activator inhibitor-1 antigen levels in hyperthyroid patients.
    Akinci B; Comlekci A; Yener S; Demir T; Ozcan MA; Bayraktar F; Yesil S
    Endocr J; 2007 Aug; 54(4):593-9. PubMed ID: 17690487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Active PAI-1 as marker for venous thromboembolism: case-control study using a comprehensive panel of PAI-1 and TAFI assays.
    Bollen L; Peetermans M; Peeters M; Van Steen K; Hoylaerts MF; Declerck PJ; Verhamme P; Gils A
    Thromb Res; 2014 Nov; 134(5):1097-102. PubMed ID: 25193405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender Differences in Fibrin Polymerization and Lysability of Fibrin in Patients with Atrial Fibrillation.
    Gram J; Skov J; Bladbjerg EM; Sidelmann J; Jespersen J
    J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):292-7. PubMed ID: 26521168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of inflammatory and hemostatic markers with stroke and thromboembolic events in atrial fibrillation: a systematic review and meta-analysis.
    Wu N; Chen X; Cai T; Wu L; Xiang Y; Zhang M; Li Y; Song Z; Zhong L
    Can J Cardiol; 2015 Mar; 31(3):278-86. PubMed ID: 25746020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of hypofibrinolysis in patients with digestive tract cancer.
    Gronostaj K; Richter P; Nowak W; Undas A
    Prz Gastroenterol; 2016; 11(2):104-10. PubMed ID: 27350837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of plasma fibrin clot lysis measured using three different assays in healthy subjects.
    Siudut J; Iwaniec T; Plens K; Pieters M; Undas A
    Thromb Res; 2021 Jan; 197():1-7. PubMed ID: 33157491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy.
    Vene N; Mavri A; Kosmelj K; Stegnar M
    Thromb Haemost; 2003 Dec; 90(6):1163-72. PubMed ID: 14652652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease.
    Paszek E; Malinowski KP; Ząbczyk M; Butenas S; Undas A
    Eur J Clin Invest; 2023 Sep; 53(9):e14007. PubMed ID: 37042848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes: synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor.
    Aso Y; Wakabayashi S; Yamamoto R; Matsutomo R; Takebayashi K; Inukai T
    Diabetes Care; 2005 Sep; 28(9):2211-6. PubMed ID: 16123492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis Profile.
    Bollen L; Vande Casteele N; Peeters M; Van Assche G; Ferrante M; Van Moerkercke W; Declerck P; Vermeire S; Gils A
    Inflamm Bowel Dis; 2015 Nov; 21(11):2540-8. PubMed ID: 26313696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
    Colucci M; D'Aprile AM; Italia A; Gresele P; Morser J; Semeraro N
    Thromb Haemost; 2001 Apr; 85(4):661-6. PubMed ID: 11341502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.
    Cellai AP; Lami D; Magi A; Liotta AA; Rogolino A; Antonucci E; Bandinelli B; Abbate R; Prisco D
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):337-44. PubMed ID: 19117964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of antithrombotic drugs on the prothrombotic state in patients with atrial fibrillation: The west Birmingham atrial fibrillation project.
    Voukalis C; Lip GYH; Shantsila E
    Thromb Res; 2021 Apr; 200():149-155. PubMed ID: 33610887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinolytic Changes in Women with Preeclampsia.
    Godtfredsen AC; Sidelmann JJ; Dolleris BB; Jørgensen JS; Johansen EKJ; Pedersen MFB; Palarasah Y; Gram JB
    Clin Appl Thromb Hemost; 2022; 28():10760296221126172. PubMed ID: 36217728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.